Profile | GDS4284 / 202278_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 750.849 | 70 |
GSM687648 | Patient 402 control | 567.31 | 65 |
GSM687653 | Patient 403 control | 714.97 | 70 |
GSM687658 | Patient 404 control | 529.815 | 65 |
GSM687663 | Patient 411 control | 588.108 | 66 |
GSM687668 | Patient 422 control | 806.107 | 71 |
GSM687673 | Patient 424 control | 636.346 | 67 |
GSM687678 | Patient 425 control | 909.335 | 72 |
GSM687683 | Patient 427 control | 332.161 | 55 |
GSM687688 | Patient 428 control | 520.798 | 64 |
GSM687695 | Patient 441 control | 479.81 | 61 |
GSM687699 | Patient 443 control | 852.164 | 71 |
GSM687704 | Patient 444 control | 437.479 | 62 |
GSM687707 | Patient 448 control | 1028.76 | 75 |
GSM687712 | Patient 449 control | 492.25 | 63 |
GSM687719 | Patient 450 control | 458.675 | 61 |
GSM687724 | Patient 451 control | 838.757 | 72 |
GSM687728 | Patient 452 control | 922.015 | 73 |
GSM687646 | Patient 401 treated 24h | 746.927 | 69 |
GSM687649 | Patient 402 treated 24h | 876.984 | 72 |
GSM687665 | Patient 411 treated 24h | 328.645 | 56 |
GSM687651 | Patient 402 treated 4 weeks | 345.388 | 57 |
GSM687667 | Patient 411 treated 4 weeks | 738.245 | 69 |
GSM687670 | Patient 422 treated 24h | 535.325 | 64 |
GSM687671 | Patient 422 treated 4 weeks | 1146.98 | 76 |
GSM687654 | Patient 403 treated 24h | 802.981 | 71 |
GSM687675 | Patient 424 treated 24h | 829.389 | 71 |
GSM687685 | Patient 427 treated 24h | 237.786 | 51 |
GSM687656 | Patient 403 treated 4 weeks | 947.034 | 73 |
GSM687677 | Patient 424 treated 4 weeks | 292.924 | 55 |
GSM687687 | Patient 427 treated 4 weeks | 850.415 | 71 |
GSM687692 | Patient 428 treated 4h | 535.803 | 64 |
GSM687716 | Patient 449 treated 4h | 482.124 | 64 |
GSM687722 | Patient 450 treated 4h | 444.164 | 61 |
GSM687680 | Patient 425 treated 24h | 566.513 | 65 |
GSM687690 | Patient 428 treated 24h | 595.635 | 67 |
GSM687700 | Patient 443 treated 24h | 536.321 | 62 |
GSM687705 | Patient 444 treated 24h | 214.886 | 51 |
GSM687714 | Patient 449 treated 24h | 600.066 | 67 |
GSM687721 | Patient 450 treated 24h | 930.673 | 73 |
GSM687682 | Patient 425 treated 4 weeks | 71.4903 | 29 |
GSM687694 | Patient 428 treated 4 weeks | 974.498 | 73 |
GSM687702 | Patient 443 treated 4 weeks | 802.306 | 70 |
GSM687718 | Patient 449 treated 4 weeks | 372.908 | 59 |
GSM687723 | Patient 450 treated 4 weeks | 544.209 | 65 |
GSM687661 | Patient 404 treated 4h | 417.214 | 60 |
GSM687710 | Patient 448 treated 4h | 917.137 | 73 |
GSM687726 | Patient 451 treated 4h | 940.702 | 73 |
GSM687730 | Patient 452 treated 4h | 53.7877 | 13 |
GSM687660 | Patient 404 treated 24h | 186.056 | 42 |
GSM687697 | Patient 441 treated 24h | 450.719 | 60 |
GSM687709 | Patient 448 treated 24h | 1115.15 | 76 |
GSM687725 | Patient 451 treated 24h | 883.473 | 72 |
GSM687729 | Patient 452 treated 24h | 851.298 | 73 |
GSM687727 | Patient 451 treated 4 weeks | 276.923 | 52 |
GSM687731 | Patient 452 treated 4 weeks | 992.783 | 74 |